SK BIOSCIENCE
SK Bioscience is a vaccine development company beyond Korea by investing and building infrastructure for continuous vaccine development .
SK BIOSCIENCE
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-07-02
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.skbioscience.co.kr
Total Employee:
11+
Status:
Active
Contact:
02-2008-2200
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag US Privacy User Signal Mechanism GlobalSign
Similar Organizations
Genevide
Genevide is a biotech company that specializes in gene research and development.
Tanvex BioPharma
Tanvex BioPharma is a biopharmaceutical company that provides drug manufacturing, sales, and distribution services.
Stock Details
Official Site Inspections
http://www.skbioscience.co.kr Semrush global rank: 1.25 M Semrush visits lastest month: 24.13 K
- Host name: ec2-13-209-51-147.ap-northeast-2.compute.amazonaws.com
- IP address: 13.209.51.147
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "SK Bioscience"
SK ๋ฐ์ด์ค์ฌ์ด์ธ์ค
SK bioscience News SK๋ฐ์ด์ค์ฌ์ด์ธ์ค, โ์๋ฌผ๋ณด์ ์ ๊ณตโ ์ฐ์ ๋ถ ์ฅ๊ด์ ์์. ์์ ํ ๊ด๋ฆฌ ๊ฒฐ๊ณผ ๊ตญ๋ด ์ ๊ณ ์ต๊ณ ์์ค ์๋ฌผ๋ณด์ ๋ฐ ์์ ๊ด๋ฆฌ ์ฐ์์ฑ ์ ์ฆ์๋ฌผ์์ /๋ณด์ ๊ด๋ จ ๊ท์ ์๋ฆฝ, ๊ธฐ๊ด ์์ํ โฆSee details»
SK bioscience
In 2014, we signed an agreement with Sanofi Pasteur, a global pharmaceutical company, to co-develop and commercialize a next-generation pneumococcal conjugate vaccine. We also launched joint vaccine development with โฆSee details»
SK bioscience - Company Profile & Staff Directory - ContactOut
At SK bioscience, we work everyday to promote human health from prevetion to cure. We have successfully developed South Korea's first COVID-19 vaccine, 'SKYCovione' through global โฆSee details»
SK bioscience
Signed agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries; 2018. SKYVaricella Inj. licensed to market, Koreaโs second โฆSee details»
SK Bioscience - Overview, News & Similar companies - ZoomInfo
View SK Bioscience (www.skbioscience.co.kr) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โฆSee details»
SK Bioscience - Crunchbase Investor Profile
SK Bioscience is a vaccine development company that invests and builds infrastructure for continuous vaccine development .See details»
SK bioscience ESG
Www.skbioscience.com: No. of Employees: 1,101: Financial Performance 1) Revenue : KRW 369.5 billion; ... Global Co-development and Technology Transfer: ... As a cell culture-based vaccine, it acquired the first World Health โฆSee details»
SK bioscience โ DCVMN
SK launched cell culture-based, trivalent and quadrivalent influenza vaccine, SKYCellflu®, in 2015 and 2016 respectively and the two products were prequalified by the World Health Organization in 2019.See details»
SK bioscience - LinkedIn
SK bioscience | 30,140 followers on LinkedIn. We promote human health, from Prevention to Cure | At SK bioscience, we work everyday to promote human health from prevetion to cure. We have ...See details»
SK Bioscience - Devex
Learn more about SK Bioscience's jobs, projects, latest news, contact information and geographical presence. R&D Goal The domestic vaccine market is worth KRW 700 billion (as โฆSee details»
SK bioscience
SK bioscience is a vaccine company spun off from SK chemicals in 2018.. Since 2008 before the spin-off from SK chemicals, we focused on premium vaccines as new-driving forces for โฆSee details»
SK Bioscience - Golden
In 2006, SK Bioscience began research for a self-developed vaccine. In 2014, the company signed an agreement with Sanofi Pasteur SA for joint R&D and the sale of next-generationโs โฆSee details»
SK Bioscience - Wikidata
SK Bioscience - Wikidata ... biotech companySee details»
SK bioscience ESG
KR. ๋ชจ๋ฐ์ผ ๋ฉ๋ด ... In 2023, SK bioscience restructured its existing Human Rights Management Council and the human rights management organization to advance human rights โฆSee details»
SK bioscience
Refers to the attitude of knowing one's work, setting challenging goals, executing them thoroughly with passion, and transferring a knowledge within the organization. "Warm Professional" refers โฆSee details»
SK bioscience to invest big in vaccines, CDMO over next 5 years
Apr 28, 2023 SK bioscience will invest 2.4 trillion won ($1.8 billion) over five years to strengthen its vaccine and contract development and manufacturing organization (CDMO) businesses, โฆSee details»
SK bioscience applies to WHO for emergency use listing for โฆ
Sep 8, 2022 JoongAng Daily Co., Ltd. | Address: 48-6 Sangamsan-ro, Mapo-gu, Seoul, Republic of Korea Business registration number: 160-86-00572 | CEO: Park Chang-hee, Cheong Chul โฆSee details»
Press releases - SK bioscience
Jun 29, 2022 Vaccine Co-Development and Technology Transfer; CDMO/CMO; ... to โGlobal Vaccine Markets and Korea´s Vaccine Imports and Exportsโ report published by Biotechnology โฆSee details»
Press releases - SK bioscience
The clinical trial was conducted in cooperation with 16 institutions, including Korea University Guro Hospital and IVI (International Vaccine Institute), a non-profit international organization. โฆSee details»